6-bromo-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile;3-(5-bromopyrazin-2-yl)-3,6-diazabicyclo[3.1.1]heptane;3-(5-bromopyrazin-2-yl)-6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]heptane;tert-butyl 3-(5-bromopyrazin-2-yl)-3,6-diazabicyclo[3.1.1]heptane-6-carboxylate;(3-cyano-6-cyclopropylpyrazolo[1,5-a]pyridin-4-yl) trifluoromethanesulfonate;6-cyclopropyl-4-hydroxypyrazolo[1,5-a]pyridine-3-carbonitrile;6-cyclopropyl-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile;bis(6-cyclopropyl-4-[5-[6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]pyrazin-2-yl]pyrazolo[1,5-a]pyridine-3-carbonitrile);2,5-dibromopyrazine;[5-[6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]pyrazin-2-yl]boronic acid

C157H156BBr6F3N48O14S — CID 165079100

About 6-bromo-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile;3-(5-bromopyrazin-2-yl)-3,6-diazabicyclo[3.1.1]heptane;3-(5-bromopyrazin-2-yl)-6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]heptane;tert-butyl 3-(5-bromopyrazin-2-yl)-3,6-diazabicyclo[3.1.1]heptane-6-carboxylate;(3-cyano-6-cyclopropylpyrazolo[1,5-a]pyridin-4-yl) trifluoromethanesulfonate;6-cyclopropyl-4-hydroxypyrazolo[1,5-a]pyridine-3-carbonitrile;6-cyclopropyl-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile;bis(6-cyclopropyl-4-[5-[6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]pyrazin-2-yl]pyrazolo[1,5-a]pyridine-3-carbonitrile);2,5-dibromopyrazine;[5-[6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]pyrazin-2-yl]boronic acid

6-bromo-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile;3-(5-bromopyrazin-2-yl)-3,6-diazabicyclo[3.1.1]heptane;3-(5-bromopyrazin-2-yl)-6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]heptane;tert-butyl 3-(5-bromopyrazin-2-yl)-3,6-diazabicyclo[3.1.1]heptane-6-carboxylate;(3-cyano-6-cyclopropylpyrazolo[1,5-a]pyridin-4-yl) trifluoromethanesulfonate;6-cyclopropyl-4-hydroxypyrazolo[1,5-a]pyridine-3-carbonitrile;6-cyclopropyl-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile;bis(6-cyclopropyl-4-[5-[6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]pyrazin-2-yl]pyrazolo[1,5-a]pyridine-3-carbonitrile);2,5-dibromopyrazine;[5-[6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]pyrazin-2-yl]boronic acid (PubChem CID 165079100) has the molecular formula C157H156BBr6F3N48O14S and a molecular weight of 3518.59 g/mol. Its IUPAC name is 6-bromo-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile;3-(5-bromopyrazin-2-yl)-3,6-diazabicyclo[3.1.1]heptane;3-(5-bromopyrazin-2-yl)-6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]heptane;tert-butyl 3-(5-bromopyrazin-2-yl)-3,6-diazabicyclo[3.1.1]heptane-6-carboxylate;(3-cyano-6-cyclopropylpyrazolo[1,5-a]pyridin-4-yl) trifluoromethanesulfonate;6-cyclopropyl-4-hydroxypyrazolo[1,5-a]pyridine-3-carbonitrile;6-cyclopropyl-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile;bis(6-cyclopropyl-4-[5-[6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]pyrazin-2-yl]pyrazolo[1,5-a]pyridine-3-carbonitrile);2,5-dibromopyrazine;[5-[6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]pyrazin-2-yl]boronic acid.

Molecular Properties

• Compound Name: 6-bromo-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile;3-(5-bromopyrazin-2-yl)-3,6-diazabicyclo[3.1.1]heptane;3-(5-bromopyrazin-2-yl)-6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]heptane;tert-butyl 3-(5-bromopyrazin-2-yl)-3,6-diazabicyclo[3.1.1]heptane-6-carboxylate;(3-cyano-6-cyclopropylpyrazolo[1,5-a]pyridin-4-yl) trifluoromethanesulfonate;6-cyclopropyl-4-hydroxypyrazolo[1,5-a]pyridine-3-carbonitrile;6-cyclopropyl-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile;bis(6-cyclopropyl-4-[5-[6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]pyrazin-2-yl]pyrazolo[1,5-a]pyridine-3-carbonitrile);2,5-dibromopyrazine;[5-[6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]pyrazin-2-yl]boronic acid
• PubChem CID: 165079100
• Molecular Formula: C157H156BBr6F3N48O14S
• Molecular Weight: 3518.59 g/mol
• Exact Mass: 3510.78
• IUPAC Name: 6-bromo-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile;3-(5-bromopyrazin-2-yl)-3,6-diazabicyclo[3.1.1]heptane;3-(5-bromopyrazin-2-yl)-6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]heptane;tert-butyl 3-(5-bromopyrazin-2-yl)-3,6-diazabicyclo[3.1.1]heptane-6-carboxylate;(3-cyano-6-cyclopropylpyrazolo[1,5-a]pyridin-4-yl) trifluoromethanesulfonate;6-cyclopropyl-4-hydroxypyrazolo[1,5-a]pyridine-3-carbonitrile;6-cyclopropyl-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile;bis(6-cyclopropyl-4-[5-[6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]pyrazin-2-yl]pyrazolo[1,5-a]pyridine-3-carbonitrile);2,5-dibromopyrazine;[5-[6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]pyrazin-2-yl]boronic acid
• SMILES: Brc1cnc(Br)cn1.Brc1cnc(N2CC3CC(C2)N3)cn1.CC(C)(C)OC(=O)N1C2CC1CN(c1cnc(Br)cn1)C2.COc1cc(Br)cn2ncc(C#N)c12.COc1cc(C2CC2)cn2ncc(C#N)c12.COc1ccc(CN2C3CC2CN(c2cnc(-c4cc(C5CC5)cn5ncc(C#N)c45)cn2)C3)cn1.COc1ccc(CN2C3CC2CN(c2cnc(-c4cc(C5CC5)cn5ncc(C#N)c45)cn2)C3)cn1.COc1ccc(CN2C3CC2CN(c2cnc(B(O)O)cn2)C3)cn1.COc1ccc(CN2C3CC2CN(c2cnc(Br)cn2)C3)cn1.N#Cc1cnn2cc(C3CC3)cc(O)c12.N#Cc1cnn2cc(C3CC3)cc(OS(=O)(=O)C(F)(F)F)c12
• InChI: InChI=1S/2C27H26N8O.C16H20BN5O3.C16H18BrN5O.C14H19BrN4O2.C12H8F3N3O3S.C12H11N3O.C11H9N3O.C9H11BrN4.C9H6BrN3O.C4H2Br2N2/c2*1-36-26-5-2-17(9-31-26)13-34-21-7-22(34)16-33(15-21)25-12-29-24(11-30-25)23-6-19(18-3-4-18)14-35-27(23)20(8-28)10-32-35;1-25-16-3-2-11(5-20-16)8-22-12-4-13(22)10-21(9-12)15-7-18-14(6-19-15)17(23)24;1-23-16-3-2-11(5-20-16)8-22-12-4-13(22)10-21(9-12)15-7-18-14(17)6-19-15;1-14(2,3)21-13(20)19-9-4-10(19)8-18(7-9)12-6-16-11(15)5-17-12;13-12(14,15)22(19,20)21-10-3-8(7-1-2-7)6-18-11(10)9(4-16)5-17-18;1-16-11-4-9(8-2-3-8)7-15-12(11)10(5-13)6-14-15;12-4-9-5-13-14-6-8(7-1-2-7)3-10(15)11(9)14;10-8-2-12-9(3-11-8)14-4-6-1-7(5-14)13-6;1-14-8-2-7(10)5-13-9(8)6(3-11)4-12-13;5-3-1-7-4(6)2-8-3/h2*2,5-6,9-12,14,18,21-22H,3-4,7,13,15-16H2,1H3;2-3,5-7,12-13,23-24H,4,8-10H2,1H3;2-3,5-7,12-13H,4,8-10H2,1H3;5-6,9-10H,4,7-8H2,1-3H3;3,5-7H,1-2H2;4,6-8H,2-3H2,1H3;3,5-7,15H,1-2H2;2-3,6-7,13H,1,4-5H2;2,4-5H,1H3;1-2H
• InChIKey: UUZMOTKPRGLDCW-UHFFFAOYSA-N
• XLogP: 21.34
• TPSA: 711.97 Ų
• H-Bond Donors: 4
• H-Bond Acceptors: 61
• Rotatable Bonds: 30
• Heavy Atoms: 230
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	3518.59
LogP ≤ 5	21.34
H-Bond Donors ≤ 5	4
H-Bond Acceptors ≤ 10	61

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'Sulfonic_acid_1', 'substructure': 'N/A'}, {'alert_name': 'triflate', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 6-bromo-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile;3-(5-bromopyrazin-2-yl)-3,6-diazabicyclo[3.1.1]heptane;3-(5-bromopyrazin-2-yl)-6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]heptane;tert-butyl 3-(5-bromopyrazin-2-yl)-3,6-diazabicyclo[3.1.1]heptane-6-carboxylate;(3-cyano-6-cyclopropylpyrazolo[1,5-a]pyridin-4-yl) trifluoromethanesulfonate;6-cyclopropyl-4-hydroxypyrazolo[1,5-a]pyridine-3-carbonitrile;6-cyclopropyl-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile;bis(6-cyclopropyl-4-[5-[6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]pyrazin-2-yl]pyrazolo[1,5-a]pyridine-3-carbonitrile);2,5-dibromopyrazine;[5-[6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]pyrazin-2-yl]boronic acid?

The IUPAC name of 6-bromo-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile;3-(5-bromopyrazin-2-yl)-3,6-diazabicyclo[3.1.1]heptane;3-(5-bromopyrazin-2-yl)-6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]heptane;tert-butyl 3-(5-bromopyrazin-2-yl)-3,6-diazabicyclo[3.1.1]heptane-6-carboxylate;(3-cyano-6-cyclopropylpyrazolo[1,5-a]pyridin-4-yl) trifluoromethanesulfonate;6-cyclopropyl-4-hydroxypyrazolo[1,5-a]pyridine-3-carbonitrile;6-cyclopropyl-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile;bis(6-cyclopropyl-4-[5-[6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]pyrazin-2-yl]pyrazolo[1,5-a]pyridine-3-carbonitrile);2,5-dibromopyrazine;[5-[6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]pyrazin-2-yl]boronic acid (CID 165079100) is 6-bromo-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile;3-(5-bromopyrazin-2-yl)-3,6-diazabicyclo[3.1.1]heptane;3-(5-bromopyrazin-2-yl)-6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]heptane;tert-butyl 3-(5-bromopyrazin-2-yl)-3,6-diazabicyclo[3.1.1]heptane-6-carboxylate;(3-cyano-6-cyclopropylpyrazolo[1,5-a]pyridin-4-yl) trifluoromethanesulfonate;6-cyclopropyl-4-hydroxypyrazolo[1,5-a]pyridine-3-carbonitrile;6-cyclopropyl-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile;bis(6-cyclopropyl-4-[5-[6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]pyrazin-2-yl]pyrazolo[1,5-a]pyridine-3-carbonitrile);2,5-dibromopyrazine;[5-[6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]pyrazin-2-yl]boronic acid.

What is the SMILES notation for 6-bromo-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile;3-(5-bromopyrazin-2-yl)-3,6-diazabicyclo[3.1.1]heptane;3-(5-bromopyrazin-2-yl)-6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]heptane;tert-butyl 3-(5-bromopyrazin-2-yl)-3,6-diazabicyclo[3.1.1]heptane-6-carboxylate;(3-cyano-6-cyclopropylpyrazolo[1,5-a]pyridin-4-yl) trifluoromethanesulfonate;6-cyclopropyl-4-hydroxypyrazolo[1,5-a]pyridine-3-carbonitrile;6-cyclopropyl-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile;bis(6-cyclopropyl-4-[5-[6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]pyrazin-2-yl]pyrazolo[1,5-a]pyridine-3-carbonitrile);2,5-dibromopyrazine;[5-[6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]pyrazin-2-yl]boronic acid?

The canonical SMILES for 6-bromo-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile;3-(5-bromopyrazin-2-yl)-3,6-diazabicyclo[3.1.1]heptane;3-(5-bromopyrazin-2-yl)-6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]heptane;tert-butyl 3-(5-bromopyrazin-2-yl)-3,6-diazabicyclo[3.1.1]heptane-6-carboxylate;(3-cyano-6-cyclopropylpyrazolo[1,5-a]pyridin-4-yl) trifluoromethanesulfonate;6-cyclopropyl-4-hydroxypyrazolo[1,5-a]pyridine-3-carbonitrile;6-cyclopropyl-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile;bis(6-cyclopropyl-4-[5-[6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]pyrazin-2-yl]pyrazolo[1,5-a]pyridine-3-carbonitrile);2,5-dibromopyrazine;[5-[6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]pyrazin-2-yl]boronic acid is Brc1cnc(Br)cn1.Brc1cnc(N2CC3CC(C2)N3)cn1.CC(C)(C)OC(=O)N1C2CC1CN(c1cnc(Br)cn1)C2.COc1cc(Br)cn2ncc(C#N)c12.COc1cc(C2CC2)cn2ncc(C#N)c12.COc1ccc(CN2C3CC2CN(c2cnc(-c4cc(C5CC5)cn5ncc(C#N)c45)cn2)C3)cn1.COc1ccc(CN2C3CC2CN(c2cnc(-c4cc(C5CC5)cn5ncc(C#N)c45)cn2)C3)cn1.COc1ccc(CN2C3CC2CN(c2cnc(B(O)O)cn2)C3)cn1.COc1ccc(CN2C3CC2CN(c2cnc(Br)cn2)C3)cn1.N#Cc1cnn2cc(C3CC3)cc(O)c12.N#Cc1cnn2cc(C3CC3)cc(OS(=O)(=O)C(F)(F)F)c12.

What is the InChIKey of 6-bromo-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile;3-(5-bromopyrazin-2-yl)-3,6-diazabicyclo[3.1.1]heptane;3-(5-bromopyrazin-2-yl)-6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]heptane;tert-butyl 3-(5-bromopyrazin-2-yl)-3,6-diazabicyclo[3.1.1]heptane-6-carboxylate;(3-cyano-6-cyclopropylpyrazolo[1,5-a]pyridin-4-yl) trifluoromethanesulfonate;6-cyclopropyl-4-hydroxypyrazolo[1,5-a]pyridine-3-carbonitrile;6-cyclopropyl-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile;bis(6-cyclopropyl-4-[5-[6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]pyrazin-2-yl]pyrazolo[1,5-a]pyridine-3-carbonitrile);2,5-dibromopyrazine;[5-[6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]pyrazin-2-yl]boronic acid?

The InChIKey is UUZMOTKPRGLDCW-UHFFFAOYSA-N. The full InChI is InChI=1S/2C27H26N8O.C16H20BN5O3.C16H18BrN5O.C14H19BrN4O2.C12H8F3N3O3S.C12H11N3O.C11H9N3O.C9H11BrN4.C9H6BrN3O.C4H2Br2N2/c2*1-36-26-5-2-17(9-31-26)13-34-21-7-22(34)16-33(15-21)25-12-29-24(11-30-25)23-6-19(18-3-4-18)14-35-27(23)20(8-28)10-32-35;1-25-16-3-2-11(5-20-16)8-22-12-4-13(22)10-21(9-12)15-7-18-14(6-19-15)17(23)24;1-23-16-3-2-11(5-20-16)8-22-12-4-13(22)10-21(9-12)15-7-18-14(17)6-19-15;1-14(2,3)21-13(20)19-9-4-10(19)8-18(7-9)12-6-16-11(15)5-17-12;13-12(14,15)22(19,20)21-10-3-8(7-1-2-7)6-18-11(10)9(4-16)5-17-18;1-16-11-4-9(8-2-3-8)7-15-12(11)10(5-13)6-14-15;12-4-9-5-13-14-6-8(7-1-2-7)3-10(15)11(9)14;10-8-2-12-9(3-11-8)14-4-6-1-7(5-14)13-6;1-14-8-2-7(10)5-13-9(8)6(3-11)4-12-13;5-3-1-7-4(6)2-8-3/h2*2,5-6,9-12,14,18,21-22H,3-4,7,13,15-16H2,1H3;2-3,5-7,12-13,23-24H,4,8-10H2,1H3;2-3,5-7,12-13H,4,8-10H2,1H3;5-6,9-10H,4,7-8H2,1-3H3;3,5-7H,1-2H2;4,6-8H,2-3H2,1H3;3,5-7,15H,1-2H2;2-3,6-7,13H,1,4-5H2;2,4-5H,1H3;1-2H.

What are the key properties of 6-bromo-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile;3-(5-bromopyrazin-2-yl)-3,6-diazabicyclo[3.1.1]heptane;3-(5-bromopyrazin-2-yl)-6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]heptane;tert-butyl 3-(5-bromopyrazin-2-yl)-3,6-diazabicyclo[3.1.1]heptane-6-carboxylate;(3-cyano-6-cyclopropylpyrazolo[1,5-a]pyridin-4-yl) trifluoromethanesulfonate;6-cyclopropyl-4-hydroxypyrazolo[1,5-a]pyridine-3-carbonitrile;6-cyclopropyl-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile;bis(6-cyclopropyl-4-[5-[6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]pyrazin-2-yl]pyrazolo[1,5-a]pyridine-3-carbonitrile);2,5-dibromopyrazine;[5-[6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]pyrazin-2-yl]boronic acid?

6-bromo-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile;3-(5-bromopyrazin-2-yl)-3,6-diazabicyclo[3.1.1]heptane;3-(5-bromopyrazin-2-yl)-6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]heptane;tert-butyl 3-(5-bromopyrazin-2-yl)-3,6-diazabicyclo[3.1.1]heptane-6-carboxylate;(3-cyano-6-cyclopropylpyrazolo[1,5-a]pyridin-4-yl) trifluoromethanesulfonate;6-cyclopropyl-4-hydroxypyrazolo[1,5-a]pyridine-3-carbonitrile;6-cyclopropyl-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile;bis(6-cyclopropyl-4-[5-[6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]pyrazin-2-yl]pyrazolo[1,5-a]pyridine-3-carbonitrile);2,5-dibromopyrazine;[5-[6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]pyrazin-2-yl]boronic acid has a molecular weight of 3518.59 g/mol, XLogP of 21.34, 30 rotatable bonds, 4 hydrogen bond donors, and 61 hydrogen bond acceptors.

Where does this data come from?

All data for 6-bromo-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile;3-(5-bromopyrazin-2-yl)-3,6-diazabicyclo[3.1.1]heptane;3-(5-bromopyrazin-2-yl)-6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]heptane;tert-butyl 3-(5-bromopyrazin-2-yl)-3,6-diazabicyclo[3.1.1]heptane-6-carboxylate;(3-cyano-6-cyclopropylpyrazolo[1,5-a]pyridin-4-yl) trifluoromethanesulfonate;6-cyclopropyl-4-hydroxypyrazolo[1,5-a]pyridine-3-carbonitrile;6-cyclopropyl-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile;bis(6-cyclopropyl-4-[5-[6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]pyrazin-2-yl]pyrazolo[1,5-a]pyridine-3-carbonitrile);2,5-dibromopyrazine;[5-[6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]pyrazin-2-yl]boronic acid is sourced from PubChem (CID 165079100), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).